Latham & Watkins represented BridgeBio in the transaction. BridgeBio Pharma (Nasdaq: BBIO) (BridgeBio or the Company), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, executed a...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Tailwind Two and Akin Gump Strauss Hauer & Feld advised Terran Orbital on the deal. Latham & Watkins represented Francisco Partners. Tailwind...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP advised Blend in the transaction, while Wachtell, Lipton, Rosen & Katz advised Mr. Cooper Group. Blend, a leader in digital lending software,...
You must be a Standard 1 Year member to access this content.
